| Literature DB >> 29500989 |
Tyler S Klann1, Joshua B Black1, Charles A Gersbach2.
Abstract
Developments in CRISPR/Cas9-based technologies provide a new paradigm in functional screening of the genome. Conventional screening methods have focused on high-throughput perturbations of the protein-coding genome with technologies such as RNAi. However, equivalent methods for perturbing the non-coding genome have not existed until recently. CRISPR-based screening of genomic DNA has enabled the study of both genes and non-coding gene regulatory elements. Here we review recent progress in assigning function to the non-coding genome using CRISPR-based genomic and epigenomic screens, and discuss the prospects of these technologies to transforming our understanding of genome structure and regulation.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29500989 PMCID: PMC6082715 DOI: 10.1016/j.copbio.2018.02.004
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN: 0958-1669 Impact factor: 9.740